" Causes of death in asthma, COPD and non-respiratory hospitalized patients: A multicentric study"

BMC Pulmonary Medicine

Volumn 13, Issue 1, 2013, Pages

  Soto Campos, Jose G ^a   Plaza, Vicente ^b   Soriano, Joan B ^c   Cabrera López, Carlos ^d   Almonacid Sánchez, Carlos ^e   Vazquez Oliva, Rosa ^f   Serrano, Jose ^g   Ballaz Quincoces, Aitor ^h   Padilla Galo, Alicia ⁱ   Santos, Vanessa ^j  

^a HOSPITAL DE JEREZ   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c Laboratory of Microbial Pathogenesis   (Spain)

^d HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^e HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^f HOSPITAL INFANTA ELENA   (Spain)

^g Hospital Comarcal d'Inca   (Spain)

^h HOSPITAL DE GALDAKAO   (Spain)

ⁱ HOSPITAL COSTA DEL SOL   (Spain)

^j Fundacion para la Gestion de la Investigacion Biomedica de Cadiz   (Spain)

more..

Author keywords

Asthma; Cardiovascular diseases; COPD; Mortality; Respiratory failure

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ACUTE RESPIRATORY FAILURE; ADULT; AGED; ARTICLE; ASTHMA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CASE CONTROL STUDY; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; FEMALE; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INFECTION; ISCHEMIC HEART DISEASE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RECORD REVIEW; MULTICENTER STUDY; OBSERVATIONAL STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PNEUMONIA; RISK FACTOR;

AGED; AGED, 80 AND OVER; ASTHMA; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CAUSE OF DEATH; FEMALE; HOSPITAL MORTALITY; HUMANS; INFECTION; MALE; MIDDLE AGED; NEOPLASMS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SPAIN;

EID: 84889829699     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-13-73     Document Type: Article

References (42)

1. Neffen H, Baena-Cagnani C, Malka S, Sole D, Sepúlveda R, Caraballo L, et al. Asthma mortality in Latin America. J Investig Allergol Clin Immunol 1997, 7:249-253.
2. Haahtela T, Klaukka T, Koskela K, Erhola M, Laitinen LA, On the behalf of the Working Group of the Asthma Programme in Finland 1994-2004 Asthma programme in Finland: a community problem needs community solutions. Thorax 2001, 56:806-814. 10.1136/thorax.56.10.806, 1745939, 11562522, On the behalf of the Working Group of the Asthma Programme in Finland 1994-2004.
3. Bellido-Casado J, Plaza V, Bardagí S, Cosano J, López Viña A, Martínez Moragón E, Rodríguez-Trigo G, Picado C, Sanchos J. Disminuye la incidencia de asma de riesgo vital en España?. Arch Bronconeumol 2006, 42:522-525.
4. López-Campos JL, Cayuela A, Rodríguez-Dominguez S, Vigil E. Temporal trends in asthma mortality over 30 years. J Asthma 2008, 45(7):611-614. 10.1080/02770900802127006, 18773336.
5. Sáchez-Bahíllo M, García-Marcos M, Pérez-Fernández V, Martínez Torres AE, Sánchez Solís M. Evolución de la mortalidad por asma en España, 1960-2005. Arch Bronconeumol 2009, 45(3):123-128. 10.1016/j.arbres.2008.05.004, 19286113.
6. GINA Global Initiative for Asthma 2009, Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop Report, http://www.ginasthma.com, GINA.
7. Guidelines for the Diagnosis and Management of Asthma 2007, US Department of Health and Human Services. National Institutes of Health. National Heart, Lung and Blood Institute. NIH Publication number 08-5846, http://www.nhlbi.nih.gov/guidelines.
8. GEMA Guía Española para el Manejo del Asma. Arch Bronconeumol 2009, 45(Supl 7):2-35. http://www.gemasma.com, GEMA.
9. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and prevention of death from asthma. N Engl J Med 2000, 343:332-336. 10.1056/NEJM200008033430504, 10922423.
10. Suissa S, Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 2001, 107:937-944. 10.1067/mai.2001.115653, 11398069.
11. Murray CJ, López AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997, 349:1498-1504. 10.1016/S0140-6736(96)07492-2, 9167458.
12. Calverley PMA, Anderson JA, Celli BR, et al. Salmeterol and fluticasone propionate and survival in COPD. N Engl J Med 2007, 356(8):775-789. 10.1056/NEJMoa063070, 17314337.
13. Anthonisen NR, Connett JE, Enright PL, Manfreda J, Lung Health Study Research group Hospitalization and mortality in the lung health study. Am J Crit Care Med 2002, 166:333-339. Lung Health Study Research group.
14. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J, Hunninghake G, Celli B, BODE Collaborative Group Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012, 186(2):155-161. 10.1164/rccm.201201-0034OC, 22561964, BODE Collaborative Group.
15. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J 2006, 28:1245-1257. 10.1183/09031936.00133805, 17138679.
16. Silverstein MD, Reed CE, O'Connell EJ, Melton LJ, O'Fallon WM, Yunginger JW. Longterm survival of a cohort of community residents of asthma. N Engl J Med 1994, 331(23):1537-1541. 10.1056/NEJM199412083312301, 7969322.
17. Camargo CA, Barr RG, Chen R, Speizer FE. Prospective study of inhaled corticosteroid use, cardiovascular mortality, and all-cause mortality in asthmatic women. Chest 2008, 134(3):546-551. 10.1378/chest.07-3126, 2643337, 18641096.
18. Jørgensen IM, Jensen VB, Bülow S, Dahm TL, Prahl P, Juel K. Asthma mortality in the Danish child population: risk factors and causes of asthma death. Pediatr Pulmonol 2003, 36(2):142-147. 10.1002/ppul.10305, 12833494.
19. De Marco R, Locatelli F, Cazzoletti L, Bugianio M, Carosso A, Marinoni A. Incidence of asthma and mortality in a cohort of young adults: a 7-year prospective study. Respir Res 2005, 6:95-104. 10.1186/1465-9921-6-95, 1201174, 16105170.
20. Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 2005, 128:2099-2107. 10.1378/chest.128.4.2099, 16236861.
21. Thomas M, Price D. Impact of comorbidities on asthma. Expert Rev Clin Immunol 2008, 4(6):731-742. 10.1586/1744666X.4.6.731, 20477123.
22. Boulet LP. Influence of comorbid conditions on asthma. Eur Respir J 2009, 33(4):897-906. 10.1183/09031936.00121308, 19336592.
23. de Llano LA P, González FC, Añón OC, Perea MP, Caruncho MV, Villar AB. Relationship between comorbidity and asthma control. Arch Bronconeumol 2010, 46(10):508-513.
24. Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2005, 2(1):8-11. 10.1513/pats.200404-032MS, 16113462.
25. Onufrak S, Abramson J, Austin H, Holguin F, McClellan W, Viola Vaccarino L. Relation of adult-onset asthma to coronary heart disease and stroke. Am J Cardiol 2008, 101(9):1247-1252. 10.1016/j.amjcard.2007.12.024, 2396340, 18435952.
26. Dogra S, Adern CI, Baker J. The relationship between age of asthma onset and cardiovascular disease in Canadians. J Asthma 2007, 44(10):849-854. 10.1080/02770900701752391, 18097862.
27. Schanen JG, Iribarren C, Shanar E, Punjabi NM, Rich SS, Sorlie PD, Folsom AR. Asthma and incident cardiovascular disease: the atherosclerosis risk in communities study. Thorax 2005, 60:633-638. 10.1136/thx.2004.026484, 1747501, 16061703.
28. Jiménez-Puente A, Perea-Milla E, Rivas-Ruiz F. Distribution and trend of deaths within the hospital environment in Spain during the 1997-2003 period. Rev Esp Salud Publica 2006, 80:377-385.
29. GOLD The Global Initiative for Chronic Obstructive Lung Disease http://www.goldcopd.org/uploads/users/files/GOLDReport07_Changes.pdf, GOLD.
30. Drummond MB, Dasenbrook EC, Pitz MW, Murphy DJ, Fan E. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008, 300(20):2407-2416. 10.1001/jama.2008.717, 19033591.
31. Singanayagam A, Chalmers JD, Akram AR, Hill AT. Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia. Eur Respir J 2011, 38:36-41. 10.1183/09031936.00077010, 21429980.
32. O'Byrne PM, Pedersen S, Carlsson LG, Radner F, Thorén A, Peterson S, Ernst P, Suissa S. Risks of pneumonia in patients with asthma taking inhaled corticosteroids. Am J Respir Crit Care Med 2011, 183(5):589-595. 10.1164/rccm.201005-0694OC, 20889908.
33. Adams RJ, Wilson DH, Taylor AW, Daly A, D́Espaignet ET, Grande ED, Ruffin RE. Coexistent chronic conditions and asthma quality of life: a population-based study. Chest 2006, 129:285-291. 10.1378/chest.129.2.285, 16478843.
34. Weatherall M, Wijesinghe M, Perrin K, Harwood M, Beasley R. Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax 2010, 65:39-43. 10.1136/thx.2009.116608, 20029037.
35. Oian FH, Zhang Q, Zhou LF, Liu H, Huang H, Zhang XL, Yin KS. High sensitivity creactive protein: a predictive marker in severe asthma. Respirology 2008, 13(5):664-669. 10.1111/j.1440-1843.2008.01314.x, 18513241.
36. Kasayama S, Tanemura M, Koya M, Fujita K, Yamamoto H, Miyatake A. Asthma is a independent risk for elevation of plasma C-reactive protein levels. Clin Chim Acta 2009, 399(1-2):79-82.
37. Siafakas NM, Antoniou KM, Tzortzaki EG. Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2007, 2(4):453-462. 2699970, 18268919.
38. Capra V, Thompson MD, Sala A, Cole DE, Folco G, Rovati GE. Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends. Med Res Rev 2007, 27(4):469-527. 10.1002/med.20071, 16894531.
39. Peter-Golden M, Henderson WR. Leukotrienes. Mechanisms of disease. N Engl J Med 2007, 357:1841-1854. 10.1056/NEJMra071371, 17978293.
40. Ingelssson E, Yin L, Bäck M. Nationwide cohort study of the leukotriene receptor antogonists montelukast and inicident or recurrent cardiovascular disease. J Allergy Clin Immunol 2012, 129(3):702-707. 10.1016/j.jaci.2011.11.052, 22244598.
41. Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care 2001, 175:661-666.
42. Prosser R, Pharm C, Smith A. The comorbidity burden of treated asthma patient population in British Columbia. Chronic Dis Can 2010, 30:46-55.